Founded with the mission to digitally revolutionize the identification of genetic diseases, ThinkGenetic leverages electronic health data and proprietary algorithms to shorten the diagnostic journey for patients with underlying genetic conditions. Their core products, FindEHR™ and FindSM™, utilize advanced AI and clinical expertise to precisely identify at-risk patients, aiming to improve early diagnosis and treatment outcomes. ThinkGenetic focuses on the healthcare market, particularly in the realm of rare diseases.
Notable affiliations include recognition from MIT and Horizon, which voted ThinkGenetic as one of the best in the world. The company has achieved significant milestones, including the development of validated algorithms that enhance patient identification accuracy. ThinkGenetic's impact is evident in its contribution to the early diagnosis of rare genetic conditions, thereby potentially improving patient care and reducing healthcare costs.
